| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |